[Federal Register: April 11, 2005 (Volume 70, Number 68)]
[Notices]
[Page 18400-18405]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr11ap05-93]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Interventions for Individuals With Fetal Alcohol Syndrome:
Transitioning Science to Community Projects
Announcement Type: New.
Funding Opportunity Number: RFA DD05-079.
Catalog of Federal Domestic Assistance Number: 93.283.
Key Dates:
Application Deadline: May 26, 2005.
I. Funding Opportunity Description
Authority: This program is authorized under Sections 317(k)(2)
and 317C of the Public Health Service Act, (42 U.S.C. 247b(k)(2) and
247b-(4), as amended.
Purpose:
The purpose of this cooperative agreement is to implement the
continuation of a directive within the Children's Health Act of 2000 to
develop and scientifically evaluate interventions for children and
adolescents affected by Fetal Alcohol Syndrome (FAS) or other
conditions resulting from prenatal alcohol exposure and their families.
Interventions were developed to (1) improve developmental outcomes, (2)
prevent secondary conditions, and (3) provide education and support to
caregivers and families. The primary objective of this program is to
translate successful or promising scientifically evaluated
interventions for children with FAS to community settings.
This program addresses the ``Healthy People 2010'' focus areas of
Substance Abuse and Maternal, Infant, and Child Health.
Measurable outcomes of the program will be in alignment with FAS-
related performance goals for the National Center on Birth Defects and
Developmental Disabilities that include establishing new, or enhancing
existing prevention programs designed to reduce the prevalence of FAS,
reduce prenatal exposure to alcohol, and improve and/or link children
currently affected by FAS to health services.
Research Objectives and Background
Development of interventions and public health programs often occur
in large research-oriented medical schools and universities. These
settings provide a large number of intellectual and logistical
resources that facilitate development of state-of-the-art interventions
and programs. Frequently however, developed programs are
[[Page 18401]]
simply released to community agencies who must determine how best to
adapt and implement the programs; otherwise the interventions languish
in scientific journals without community implementation. This program
seeks to bridge the transition between research-based development of
interventions and community implementation of these interventions.
The benefit of intervention, especially early intervention, for
individuals with developmental disabilities has long been proven in the
scientific and community programs literatures. Until recently,
information and strategies for interventions specific to individuals
with FAS has been gleaned from other disabilities, and the wisdom
gained by parents has been achieved through trial and error and shared
through informal networks. Although informative to a limited degree,
such treatments have been implemented without being evaluated
systematically or scientifically.
To increase scientific understanding of the spectrum of disorders
associated with prenatal alcohol exposure, recipients should develop
mechanisms to obtain neuro-development assessment data from children
participating in the community-based interventions, and estimate and
compare economic costs and benefits of prescribed interventions in the
community setting.
Hence, the approach of the current cooperative agreement (RFA DD05-
079) will be for each funded site to work with a community agency to
adapt their program to the community setting. In the later stages of
the program, each site will document the intervention process such as
through a working manual or guidance, and initiate a train-the-trainer
type program to facilitate even broader dissemination of these
scientifically evaluated interventions for children with FAS.
In 2001, CDC provided the first federal funding to develop
systematic, specific, and scientifically evaluated interventions
appropriate for children with FAS and their families.
Under that competitive announcement, awards were made to five
recipients to conduct interventions with the aim of improving the
developmental outcomes of individuals with FAS, reducing secondary
conditions, and improving the lives of families affected by FAS.
For each site, children in both treatment and control groups
received comprehensive multi-disciplinary assessments that guided
referrals for standard care and services as indicated (e.g., speech
therapy, special education). Beyond assessment and standard care,
children in the treatment groups also received interventions
specifically designed to focus on one of the core vulnerabilities
associated with FAS: mathematical skills, social communication, peer
relations, foster care stability, compliance, learning readiness, and
challenging behaviors. All sites included specific instruction and
training for parents and caregivers as part of the treatment process.
Final analyses and submission of articles to scientific journals is
anticipated in late 2005.
Thus, this announcement seeks to build upon previous activities and
foundation building in partnering with community agencies, employing a
study design to include outcome assessment data and documenting
performance toward process and time-bounded objectives, and
implementing a dissemination program to publicize approaches,
collaborations, and results.
In effect, these five recipients should have completed or be
nearing completion of intervention research that has: Concluded data
collection; completed or is advanced in data analysis; measured
behavioral and/or health outcomes related to intervention(s) for
individuals with prenatal alcohol exposure; collected pre- and post-
test data, used treatment and control/comparison groups with random
assignment; and evaluated the effectiveness of intervention(s) using
quantitative statistics.
Activities
Project activities should focus on tailoring and adapting a proven
intervention to community settings and facilitating start-up
activities. Awardee activities for this program are as follows:
1. Translate scientifically evaluated interventions for children
with a Fetal Alcohol Syndrome Disorder (FASD) for use in community
settings through partnership with a community agency (e.g., school,
health department, state service organization) and to adapt each
intervention to the resources; infrastructure, and personnel of their
partner;
2. Demonstrate the utility and scientific credibility of developed
materials and training of community agencies for implementing these
interventions toward enhancing cognitive, developmental, or behavioral
outcomes for children with FASD;
3. Work with partner agency to develop outreach and recruitment
procedures for identification of affected children and their families
from multiple sources to maximize the possibility of ascertaining
participants;
4. Develop mechanisms to identify core elements of intervention
necessary to ensure fidelity of implementation;
5. Disseminate these scientifically evaluated and proven credible
interventions for children with FAS by development of a train-the-
trainer or other similar programs to be offered to appropriate
professionals (e.g., medical and allied health, education, case
managers, etc);
6. Facilitate definition of the full spectrum of neuro-
developmental disabilities associated with prenatal exposure to alcohol
and its consequences by development of a cross-site collaborative
database including: (a) Neuro-developmental testing results for
children with FAS or other prenatal alcohol exposure related conditions
in the community setting; and (b) outcomes;
7. Subsequent to definition of variables to be included in
development of the database and the convening of investigators from
other funded projects, discuss and develop a common protocol that could
be implemented for obtaining assessment data from children, and in
determining outcomes, costs and benefits of each intervention;
8. Prepare scientific reports for publication that document the
translated research study findings. The dissemination effort should
seek to convert interventions into packages of ``how to'' materials for
use in community settings for implementing the target intervention.
CDC Responsibilities
In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine grant monitoring. In
this cooperative agreement, CDC Scientists (Scientific Collaborator)
within the National Center on Birth Defects and Developmental
Disabilities (NCBDDD) are an equal partner with scientific and
programmatic involvement during the conduct of the project through
technical assistance, advice, and coordination. Scientific
Collaborators will:
1. Use their experience in studies of this nature to advise the
project on specific questions regarding the project-developed protocol;
2. As requested, assist the project in responding to inquiries
regarding such areas as data management, data analysis, intervention
design, family dynamics, formats for presenting research findings, and
in comparing project-developed evaluation formats with other research
projects and activities known to CDC;
3. Provide scientific consultation and technical assistance as
requested on questions related to epidemiology,
[[Page 18402]]
statistical and power calculations, and data storage and tracking
formats used in other CDC sponsored research that could be advantageous
to the project; and
4. Suggest to the project upon request; processes for analysis,
interpretation, and reporting of findings in the literature that can
serve a broad range of scientific interests.
CDC Scientific Program Administrator (SPA)
The CDC NCBDDD will appoint an SPA, apart from the NCBDDD
Scientific Collaborator who will:
1. Serve as the Program Official for the funded research
institutions.
2. Carry out continuous review of all activities to ensure
objectives are being met.
3. Attend Coordinating Committee meetings for purposes of assessing
overall progress and for program evaluation purposes.
4. Provide scientific consultation and technical assistance in the
conduct of the project as requested.
5. Conduct site visits to recipient institutions to determine the
adequacy of the research and to monitor performance against approved
project objectives.
Collaborative Responsibilities
The planning and implementation of the cooperative aspects of the
study will be effected by a coordinating committee consisting of the
Principal Investigator from the organizations receiving awards under
this program and the CDC Scientific Collaborator. Organizations serving
as sub-contractors under awarded projects are not considered members of
the coordinating committee. This coordinating committee will formulate
a plan for cooperative research and address issues of common concern
throughout the life of the project.
At periodic coordination committee meetings, the group will: (1)
Make recommendations on the study protocol and data collection
approaches; (2) discuss common protocols as they relate to neuro-
development assessment data from children participating in community-
based interventions, development of a cross-site collaborative database
of testing results, and collecting cost estimates for each
intervention; (3) discuss the target populations that have been or will
be recruited; (4) identify and recommend solutions to unexpected study
problems; and (5) discuss ways to efficiently coordinate study
activities and best practices.
II. Award Information
Type of Award: Cooperative agreement.
CDC involvement in this program is listed in the Activities Section
above.
Mechanism of Support: U84 (The Administrative Code for FAS
cooperative agreements).
Fiscal Year Funds: 2005.
Approximate Total Funding: $1,500,000. The estimated funding amount
is pending availability of FY 2005 funds, and is subject to change.
Approximate Number of Awards: Five.
Approximate Average Award: $300,000. This amount is for the first
12-month budget period for each of the five awarded projects, and
includes both direct and indirect costs.
Floor of Award Range: $300,000.
Ceiling of Award Range: $300,000.
Anticipated Award Date: August 1, 2005.
Budget Period Length: 12 months.
Project Period Length: Four Years. Throughout the project period,
CDC's commitment to continuation of awards will be conditioned on the
availability of funds, evidence of satisfactory progress by the
recipient (as documented in required reports), and the determination
that continued funding is in the best interest of the Federal
government.
III. Eligibility Information
III.I. Eligible Applicants
Eligibility is limited to those projects previously funded under
CDC Program Announcement Number 01074; FAS Neuro-development Disorders
in Children and/or Adolescents. They include the University of
California, Los Angeles; Children's Research Triangle, Chicago, IL;
Kennedy Krieger Institute, Baltimore, MD (with the project located at
the Marcus Institute in Atlanta, GA); University of Oklahoma Health
Sciences Center; and the University of Washington. This limited
eligibility is based on sustaining support to well-established
projects, and to take advantage of the foundation and multiple systems
developed over time and now in place to identify and impact on the
lives of individuals with FAS and their families.
III.2. Cost Sharing or Matching
Matching funds are not required for this program.
III.3. Other
If you request a funding level greater than the upper threshold,
your application will not be eligible for review. You will be notified
that you did not meet submission requirements.
Special Requirements
If your application is incomplete or non-responsive to the
requirements listed below, it will not be entered into the review
process. You will be notified that your application did not meet
submission requirements.
Applicants must document their present infrastructure, capacity,
expertise, and experience (within organization or within organizations
of collaborators) in conducting research directly related to the
awardee activities cited in this announcement.
Note: Title 2 of the United States Code Section 1611 states that
an organization described in Section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant, or loan.
Individuals Eligible to Become Principal Investigators: Any
individual with the skills, knowledge, and resources necessary to carry
out the proposed research is invited to work with their institution to
develop an application for support. Individuals from under-represented
racial and ethnic groups as well as individuals with disabilities are
always encouraged to apply for CDC programs.
IV. Application and Submission Information
IV.1 Address To Request Application Package
To apply for this funding opportunity, use application form PHS 398
(OMB number 0925-0001 rev. 11/2004). Forms and instructions are
available in an interactive format on the CDC Web site, at the
following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm.
Forms and instructions are also available in an interactive format
on the National Institutes of Health (NIH) Web site at the following
Internet address: http://grants.nih.gov/grants/funding/phs398/phs398.html
.
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to
you.
IV.2. Content and Form of Application Submission
Application: Follow the PHS 398 application instructions for
content and formatting of your application. If the instructions in this
announcement differ in any way from the PHS 398 instructions, follow
the instructions in this announcement. For further
[[Page 18403]]
assistance with the PHS 398 application form, contact PGO-TIM staff at
(770) 488-2700, or contact Grants Info, Telephone (301) 435-0714, E-
mail: GrantsInfo@nih.gov.
You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. Your DUNS number must be entered
on line 11 of the face page of the PHS 398 application form. The DUNS
number is a nine-digit identification number, which uniquely identifies
business entities. Obtaining a DUNS number is easy and there is no
charge. To obtain a DUNS number, access http://www.dunandbradstreet.com or
call 1-866-705-5711. For more information, see the CDC Web site at:
http://www.cdc.gov/od/pgo/funding/pubcommt.htm.
This announcement uses the non-modular budgeting format. See:
http://grants.nih.gov/grants/funding/modular/modular.htm.
The PHS 398 grant application form requires the applicant to enter
the project title on page 1 (Form AA, ``Face Page'') and the project
description (abstract on page 2).
The main body of the application narrative should not exceed 25
single-spaced pages. This narrative research plan should address
activities to be conducted over the entire project period.
Additional information may be included in the application
appendices. The appendices will not be counted toward the narrative
page limit. This additional information may include curriculum vitae
and r[eacute]sum[eacute]s for key project staff, organizational charts,
letters of commitment and support, graphic work plan with time
intervals related to goals and objectives, etc.; and should be limited
to those items relevant to the requirements of this announcement.
Applicants must provide a graphic work plan that outlines major goals
and objectives with timelines established for each calendar quarter
covering the entire project period.
All material must be typewritten, with 10 characters per inch type
(12 point) on 8 -\1/2\ by 11 inch white paper with one inch margins, no
headers or footers (except for applicant-produced forms such as
organizational charts, c. vitae, graphs and tables, etc). Applications
must be held together only by rubber bands or metal clips, and not
bound together in anyway (including attachments/appendices).
Additional requirements that may require you to submit additional
documentation with your application are listed in section ``VI.2.
Administrative and National Policy Requirements.''
IV.3. Submission Dates and Time
Application Deadline Date: May 26, 2005.
Explanation of Deadlines: Applications must be received in the CDC
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline
date. If you send your application by the appropriate postal service or
commercial delivery service, you must ensure that the carrier will be
able to guarantee delivery of the application by the closing date and
time. If CDC receives your application after closing due to: (1)
Carrier error, when the carrier accepted the package with a guarantee
for delivery by the closing date and time, or (2) significant weather
delays or natural disasters, you will be given the opportunity to
submit documentation of the carrier's guarantee. If the documentation
verifies a carrier problem, CDC will consider the application as having
been received by the deadline.
This announcement is the definitive guide on the application
submission address and deadline. It supersedes information provided in
the application instructions. If your application does not meet the
deadline above, it will not be eligible for review, and will be
discarded. You will be notified that your application did not meet the
submission requirements.
CDC will not notify you upon receipt of your submission. If you
have a question about the receipt of your application, first contact
your courier. If you still have a question, contact the PGO-TIM staff
at: 770-488-2700. Before calling, please wait two to three days after
the submission deadline. This will allow time for submissions to be
processed and logged.
IV.4. Intergovernmental Review of Applications
Executive Order 12372 does not apply to this program.
IV.5. Funding Restrictions
Restrictions, which must be taken into account while writing your
budget are:
Project funds cannot be used to supplant other available
applicant or collaborating agency funds for construction or for lease
or purchase of facilities or space.
Funds may be spent for reasonable program purposes,
including personnel, travel, supplies, and services. Equipment may be
purchased if deemed necessary to accomplish program objectives,
however, prior approval by CDC officials must be requested in writing.
The applicant may contract with other organizations under
this program; however the applicant must perform a substantial portion
of the activities (including program management and operations, and
delivery of prevention services for which funds are required).
If you are requesting indirect costs in your budget, you
must include a copy of your indirect cost rate agreement. If your
indirect cost rate is a provisional rate, the agreement must be less
than 12 months from the application due date.
IV.6. Other Submission Requirements
Application Submission Address: Submit the original and one hard
copy of your application by mail or express delivery service to:
Technical Information Management--RFA DD05-079, CDC Procurement and
Grants Office, 2920 Brandywine Road, Atlanta, Georgia 30341.
At the time of submission, four additional copies of the
application, and all appendices must be sent via overnight commercial
carrier to: Dr. Kathleen Madden, Office of Public Health Research
(OPHR), 1 West Court Square, Suite 7000, Room 7008, Mailstop D-72,
Decatur, Georgia 30030, E-mail address: kmn0@cdc.gov.
V. Application Review Information:
V.1. Criteria
You are required to provide measures of outcome and effectiveness
that will demonstrate the accomplishment of the various identified
objectives for each stage of the cooperative agreement. Measures of
effectiveness must relate to the performance goals stated in the
``Purpose'' section of this announcement. Measures must be objective
and quantitative, and must measure the intended outcome. These measures
of effectiveness must be submitted with the application and will be an
element of evaluation.
In the written comments, reviewers will be asked to evaluate the
application in order to judge the likelihood that the proposed research
will have a substantial impact on the pursuit of these goals. The
scientific review group will address the applications' overall score,
weighting them as appropriate for each application. The application
does not need to be strong in all categories to be judged likely to
have major scientific impact and thus deserve a high priority score.
Under the evaluation criteria noted below, applicants must describe
how they will address the program components as they relate to the
[[Page 18404]]
Purpose and Research Objectives, and Recipient Activities as cited in
this Announcement.
Your application will be evaluated against the following criteria.
Please ensure that your narrative describes not only what will be done,
but how and through what tasks and activities the work will be
undertaken:
1. Resources and Organizational Capacity, including but not limited
to applicant experience, within its organization and with collaborating
partners to meet all the requirements of this announcement; and a
demonstrated ability to assemble a team with the experience and time
commitments to dedicate full attention to all planning, implementation,
and outcome assessment components of the project.
2. Methods and Activities, including but not limited to ensuring
that proposed methods and activities convincingly and comprehensively
meet the intention and goals of the announcement; that the methods and
activities are feasible within scientific, programmatic and fiscal
constraints and will produce accurate, valid and reliable data; that
the calculated statistical power and the potential capacity of the
research design is adequate to generate meaningful results during the
study period; and that the design can be easily replicated for future
use by sponsoring organizations including the dissemination of findings
and recommendations for the benefit of other agencies.
3. Management, Staffing, and Objectives, including evidence that
the applicant has sufficient scientific and management resources for
project planning and data management/analysis; that the proposed
staffing, staff qualifications, experience, and project organization
are sufficient to accomplish the objectives of the program; and that
the project goals and objectives can be accomplished through the
proposed methods and within the proposed timeline.
4. Evaluation Plan, including that the evaluation components
described in the announcement have been addressed in the proposal; that
the measurable objectives included in the methods proposed are
appropriate for the measurable objectives; and that the evaluation plan
includes a process for overall evaluation of sub-components and the
entire project, including the assignment of responsibility for ongoing
review of all specified components.
5. Budget Description and Justification, including the
comprehensiveness and adequacy of the proposed budget in relation to
program operations, collaborations, and services; and the extent to
which the budget is reasonable, clearly justified, accurate, and
consistent with the purposes of this research.
6. Protections: Does the application adequately address the
requirements of 45 CFR Part 46 for the protection of human subjects?
This criteria will not be scored; however, an application can be
disapproved if the research risks are sufficiently serious and
protection against risks is so inadequate as to make the entire
application unacceptable.
7. Inclusion: Does the application adequately address the CDC
policy requirements regarding the inclusion of women, ethnic, and
racial groups in the proposed research? This includes:
a. The proposed plan for the inclusion of both sexes and racial and
ethnic minority populations for appropriate representation.
b. The proposed justification when representation is limited or
absent.
c. A statement as to whether the design of the study is adequate to
measure differences when warranted.
d. A statement as to whether the plans for recruitment and outreach
for study participants include the process of establishing partnerships
with community(ies) and recognition of mutual benefits.
V.2. Review and Selection Process
Applications will be reviewed for completeness by the Procurement
and Grants Office (PGO) and for responsiveness by OPHR. Incomplete
applications and applications that are non-responsive as to the
eligibility criteria and other eligibility requirements will not
advance through the review process. Applicants will be notified that
their application did not meet submission requirements and will not
receive further consideration.
Applications, which are complete and responsive, will be subjected
to a preliminary evaluation (triage) by the scientific review group
(Special Emphasis Panel--SEP) composed of external (non-CDC) peer
reviewers to determine if the application is of sufficient technical
and scientific merit to warrant further review by the SEP. Applications
that are determined to be non-competitive will not be considered.
Subsequent to the review meeting CDC will notify the investigator/
program director and the official signing for the applicant
organization of that determination.
Applications determined to be competitive will then be reviewed and
scored under the formal SEP peer review process. The review of these
fully competitive applications will result in the determination of the
score and ranking for those applications.
Subsequent to the formal peer review by the SEP, a second level of
review will be conducted by senior CDC program staff. This review is
not intended to revisit the scientific merit of the applications. It is
designed to review and discuss issues related to the adequacy and
justification of the proposed budgets and funding ceilings, and to
review the overall rating and ranking of all recommended applications.
This will be done in order to prepare recommendations for funding based
on the scientific merit as determined by the SEP; and to ensure that
the recommendations are consistent and compatible with the Review and
Selection section of the original program announcement.
V.3. Anticipated Award Date:
August 1, 2005.
VI. Award Administration Information
VI.1. Award Notices: If your application is to be funded, you will
receive a Notice of Award (NoA) from the CDC Procurement and Grants
Office. The NoA shall be the only binding, authorizing document between
the recipient and CDC. The NoA will be signed by an authorized Grants
Management Officer and mailed to the recipient fiscal officer
identified in the application.
Unsuccessful applicants will receive notification of the results of
the application review by mail.
VI.2. Administrative and National Policy Requirements
45 CFR Parts 74 and 92.
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html. The
following additional requirements apply to this project:
AR-1: Human Subjects Requirements
AR-2: Requirement for Inclusion of Women and Racial and Ethnic
Minorities in Research
AR-10: Smoke-Free Workplace Requirements
AR-11: Healthy People 2010
AR-12: Lobbying Restrictions
AR-22: Research Integrity
AR-25: Release and Sharing of Data
Projects that involve the collection of information from 10 or more
individuals and funded by cooperative agreement will be subject to
review by the Office of Management and Budget under the Paperwork
Reduction Act.
Additional information on these requirements can be found on the
CDC
[[Page 18405]]
web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.
VI.3. Reporting
You must provide CDC with an original, plus two copies of the
following reports:
1. Interim progress report, (PHS 2590, OMB Number 0925-0001, rev.
11/2004), on a date to be determined for your project for each
subsequent budget year. The progress report will serve as your non-
competing continuation application, and must contain the following
elements:
a. Current Budget Period Activities and Objectives.
b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activities and Objectives.
d. Budget.
e. Additional Requested Information.
f. Measures of Effectiveness.
2. Financial status report and annual report, no more than 90 days
after the end of the budget period.
3. Final financial and performance reports, no more than 90 days
after the end of the project period.
These reports must be sent to the Grants Management Specialist
listed in the ``Agency Contacts'' section of this announcement.
VII. Agency Contacts
We encourage inquiries concerning this announcement. For general
questions contact: Technical Information Management Section (PGO-TIM),
CDC Procurement and Grants Office, 2920 Brandywine Road, Atlanta,
Georgia 30341, Telephone: 770-488-2700.
For program technical assistance, contact: Don Lollar, Ed.D.,
National Center on Birth Defects and Developmental Disabilities, CDC,
1600 Clifton Road, Mailstop E-87, Atlanta, Georgia 30333, E-Mail
Address: dlollar@cdc.gov. Telephone: 404-498-3041.
For budget assistance, contact: Nealean Austin, Grants Management
Specialist, CDC Procurement and Grants Office, 2920 Brandywine Road,
Atlanta, Georgia 30341, Telephone: 770-488-2814, E-mail:
naustin@cdc.gov.
VIII. Other Information
This and other CDC funding opportunity announcements can be found
on the CDC web site, Internet address: http://www.cdc.gov. Click on
``Funding'' then ``Grants and Cooperative Agreements.''
Dated: April 5, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention.
[FR Doc. 05-7147 Filed 4-8-05; 8:45 am]
BILLING CODE 4163-18-P